Vacci-nation: A case study in health and prosperity
Article
Vaccines have been integral to health and prosperity in the last three centuries.
The Covid-19 vaccination has again demonstrated the value of vaccines – to lives, livelihoods, and national prosperity. Despite that success, it is imperative that the UK isn’t complacent: there is still huge room for improvement.
Doing better on vaccines could support population health, NHS system readiness and the economy. The key lesson from the Covid-19 vaccination programme is that an overly individualised approach to vaccine uptake and inequality is fundamentally limited.
On that basis, our policy recommendations explore how we can move ahead on vaccines, by harnessing the role of innovation, a wider range of public institutions, government, and businesses to support equality in access, uptake, and outcomes.
Related items
Navigating in the fog: Why the OBR should hold its nerve on the productivity forecast
The fiscal watchdog is under pressure to downgrade its forecast, costing the chancellor billions – but this would be premature.Everyday concerns: What people want from transport
Transport has a key role to play in achieving the UK government's missions and improving lives.Reforming gambling taxation: How to lift half a million children out of poverty
A key priority for the government’s upcoming child poverty strategy should be to remove the two-child limit and scrap the household benefit cap.